An Overview of the UroLift® System
Benign prostatic hyperplasia (BPH) is commonly known as an enlarged prostate. This noncancerous, benign enlargement of the prostate gland commonly causes men to experience an increased urge of urination followed by a persistently slow urine flow and difficulty starting urination. Patients in the Plano, Frisco and Dallas, Texas area can now turn to urologist Dr. Mark Allen for a new, minimally invasive BPH treatment option, known as the UroLift® System.
What is an Enlarged Prostate?
A number of men over the age of 50 experience difficulties with urination caused by an enlarged prostate. Benign prostatic hyperplasia (BPH), otherwise known as an enlarged prostate, is caused when prostate cells multiply gradually and cause an enlargement that places pressure on the urethra.
An enlarged prostate can cause:
- Weak or slow urine flow
- Feeling of incomplete bladder emptying
- Frequent urination
- Straining to urinate
The UroLift System Redefines BPH Treatment
Men suffering from an enlarged prostate now have a new BPH treatment option, the UroLift System. The UroLift System is an FDA approved, minimally invasive device designed to lift and hold the tissue of an enlarged prostate so it no longer blocks the urethra and causes urination issues.
The UroLift System is a straightforward procedure that uses tiny, permanent implants to lift and hold the enlarged prostate tissue. This BPH treatment requires no invasive cutting, heating or removal of prostate tissue. Many patients can expect 4-5 UroLift implants to be placed by Dr. Allen into the prostate.
Clinical data has shown that the UroLift System is a safe and effective BPH treatment option. The data has proven the implants can improve symptoms associated with an enlarged prostate 3 to 4 times greater than medication. Results have also shown up to two years durability with no impact to sexual function.
Who is an Ideal Candidate for the UroLift System?
Dr. Allen will perform a thorough medical examination and a number of tests to determine if a patient is a candidate for the UroLift System. UroLift is an appropriate BPH treatment for many patients seeking a minimally invasive approach when medications no longer work and are concerned about preserving sexual function.
The most common side effects include small amounts of blood in the urine, urine urgency, pelvic ache and painful urination. The majority of patients experience a decrease of symptoms in four weeks or less. Patients report returning to normal daily activities in approximately 7-10 days after the UroLift System is administered.
For more resources on an enlarged prostate, or for more information on UroLift as a BPH treatment, please contact the Plano, Frisco and Dallas, Texas urology office of Dr. Mark Allen.